PROSTATESENTRY

PROSTATESENTRY Canadian Trademark Information

Blood drawing apparatus; diagnostic kits, namely laboratory assay kits and blood testing kits for use in clinical, laboratory, medical and chemical research and development and used to diagnose, prognose, predict or treat diseases, and laboratory assay kits and blood testing kits for identifying disease risk factors and responses to therapeutic treatment; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease, response to external stimuli, or response to therapeutic treatment. Diagnostic services, namely diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, namely clinical laboratory testing services, patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients, diagnosing, preve...

Words that describe this mark

blood   drawing   apparatus   diagnostic   kits     laboratory   assay   kits   blood   testing   kits   use   clinical     laboratory     medical   chemical   research   development   used   diagnose     prognose     predict   treat   diseases     laboratory   assay   kits   blood   testing   kits   identifying  
On Tuesday, May 1, 2012, a canadian trademark registration was filed for PROSTATESENTRY by GeneNews Limited 445 Apple Creek Blvd., Unit 220, Markham, ONTARIO, CANADA L3R9X7. The Canadian IP office has given the trademark application number of 1575810. The current status of this trademark filing is Interruption of proceeding. The correspondent listed for PROSTATESENTRY is BORDEN LADNER GERVAIS LLP of Bay Adelaide Centre, East Tower, 22 Adelaide St. West, TORONTO, ONTARIO, CANADA M5H4E3 The PROSTATESENTRY trademark is filed in the description of Blood drawing apparatus; diagnostic kits, namely laboratory assay kits and blood testing kits for use in clinical, laboratory, medical and chemical research and development and used to diagnose, prognose, predict or treat diseases, and laboratory assay kits and blood testing kits for identifying disease risk factors and responses to therapeutic treatment; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease, response to external stimuli, or response to therapeutic treatment. , Diagnostic services, namely diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, namely clinical laboratory testing services, patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; medical and diagnostic services, namely evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; research and development and product development in the fields of molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, namely providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products; computer services, namely computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; computer services, namely maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks. .
Word Mark: PROSTATESENTRY
Current Status:
Interruption of proceeding
LIVE Mark!
10/5/2016
Application Number: 1575810
Filing Date: Tuesday, May 1, 2012
Filing Place: Canada
Registration Date: Monday, January 1, 1900
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Word
Use In Commerce: No
Publication Registration: Wednesday, May 27, 2015
Opposition: 5/27/2015 - 5/27/2015
Last Applicant/Owner: 445 Apple Creek Blvd.
Unit 220
Markham
ONTARIO
CANADA L3R9X7
Correspondent:
Bay Adelaide Centre, East Tower
22 Adelaide St. West
TORONTO
ONTARIO
CANADA M5H4E3
Goods and Services Information
Description:
(1) - Blood drawing apparatus; diagnostic kits, namely laboratory assay kits and blood testing kits for use in clinical, laboratory, medical and chemical research and development and used to diagnose, prognose, predict or treat diseases, and laboratory assay kits and blood testing kits for identifying disease risk factors and responses to therapeutic treatment; diagnostic kits comprising molecular biological reagents useful for detecting gene expression products, including ribonucleic acid (RNA) or proteins, as an indication of body state, including body health, condition, disease, response to external stimuli, or response to therapeutic treatment.
(2) - Diagnostic services, namely diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical and diagnostic services, namely clinical laboratory testing services, patient triage or risk stratification services, including determination of likelihood or odds of having a particular disease or condition as an aid to optimize further testing or treatment options for patients, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity, and monitoring of patient health progression; medical and diagnostic services, namely evaluating clinical trial progress, and drug monitoring; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating treatment progression, and prognosing disease or disease progression; providing genomic, proteomic and gene expression profiles useful in evaluating the efficacy and toxicity of treatments, and identifying disease heredity risk factors; research and development and product development in the fields of molecular biology, genomics, proteomics, diagnostics, toxicogenomics, pharmacogenomics and personalized medicine; computer services, namely providing a website for patients and medical professionals featuring educational information about personalized health management, disease, and disease risk assessment services and screening products; computer services, namely computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics; computer services, namely maintaining and providing access to a patient registry containing personalized health management information accessible via global, national and local computer networks.

Classification Information

Class Code: 001 - Chemical Products
Description: Chemicals and adhesives
Class Code: 010 - Medical Instrument Products
Description: Medical and veterinary devices
Class Code: 038 - Communications Services
Description: Telecommunications
Class Code: 041 - Education and Entertainment Services
Description: Education; providing of training; entertainment, sporting and cultural activities
Class Code: 042 - Computer & Software Services & Scientific Services
Description: Computer and scientific
Class Code: 044 - Medical, Beauty & Agricultural Services
Description: Medical and veterinary, beauty, agricultural and forestry
Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals, herbicides and veterinary products

Matter History Events

Status Date: Record Status Description
2016-10-05 National prosecution history entry - abandoned - Subsection 40(3)
2016-03-11 National prosecution history entry - extension of time
2016-01-11 National prosecution history entry - Record Security Interest / License Agreement
2015-09-11 National prosecution history entry - allowed
2015-09-11 National prosecution history entry - allowance notice sent
2015-05-27 Application published - advertised
2015-05-22 National prosecution history entry - Extracted for Advertisement
2015-05-07 Application accepted - approved
2015-03-16 National prosecution history entry - approval notice sent
2015-02-04 National prosecution history entry - Amendment to Application
2014-09-18 National prosecution history entry - extension of time
2014-04-24 National prosecution history entry - Amendment to Application
2014-03-11 National prosecution history entry - correspondence created
2013-05-27 National prosecution history entry - extension of time
2012-11-13 Filing date accorded - Search Recorded
2012-11-13 National prosecution history entry - Examiner's First Report
2012-05-07 Filing date accorded - formalized
2012-05-01 Application filed - filed
2012-05-01 National prosecution history entry - created
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 180+ countries.
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!